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ABSTRACT
Pax genes encode a family of transcription factors that have long been recognised as obligate
contributors to embryonic development of the CNS, with evidence obtained from various
animal models illustrating phylogenetically conserved functions. Within the CNS, Pax genes
play substantial roles in cellular and regional specification, proliferation, progenitor cell
maintenance, anti-apoptosis and neural differentiation. This comprehensive review details the
critical functions of those Pax genes involved in pre- and post-natal CNS development,
provides possible molecular mechanisms by which Pax genes contribute to proliferation and
differentiation of neuronal cells, and explains observed changes in Pax gene expression in
response to neurotrauma in the mature animal.

Knowledge of the ability of individual Pax genes to specify precise lineages within the CNS
is beneficial for cell replacement strategies, particularly in the production of “designer” cells
for the treatment of neurodegenerative disorders. The manipulation of stem or committed
cells so that they express definitive Pax genes may indeed assist in the pursuit of the holy
grail of regenerative medicine – that of CNS cell replacement therapies leading to functional
repair. We explain here, however, that only the sophisticated and precise use of Pax genes
will lead to a successful outcome.
KEYWORDS
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ABBREVIATIONS
bHLH, basic helix-loop-helix: cdk, cyclin-dependent kinases: CNS, central nervous system:
GABA, gamma-aminobutyric acid: N-CAM, neural cellular adhesion molecule: Ng-CAM,
neuron-glia cellular adhesion molecule: PSA-NCAM, polysialylated neural cellular adhesion
molecule; SGZ, subgranular zone: SVZ, subventricular zone: TERT, Telomerase Reverse
Transcriptase.
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1.

INTRODUCTION

Central nervous system (CNS) repair remains an elusive target for biomedical research, due
to the poor regenerative capacity and as yet intractable complexity of the CNS. Stem cell
transplantation offers great promise for repair subsequent to neurodegenerative diseases,
neurotrauma or maldevelopment. Treatment with replacement cells, however, will require indepth knowledge of the genes/factors that control precursor cell development towards a fully
functional, differentiated neural cell of a specific CNS region. Manipulation may be required
3

to direct cells along the appropriate neural lineage for replacement of lost or damaged cells
for a specific CNS target region. The capacity of developmental genes to “prime” stem cells
or modify their developmental pathways prior to transplantation is a tool currently being
investigated by several laboratories worldwide (Berninger et al., 2007; Cao et al., 2005;
Denham et al., 2010; Heins et al., 2002; Kayama et al., 2009; Pera and Tam, 2010; Thomas
et al., 2009). As requisite orchestrators of CNS development, controlling cell specification
from very early stages, Pax genes are likely candidates to augment cell transplantation
therapies.
2.

PAX GENES – DEVELOPMENT AND DIVERSITY

Pax genes encode multiple homologous Pax proteins which have all arisen from a single
ancestral gene by gene duplication and mutation during evolution. Pax gene groups are
defined by sequence homology, and more specifically by the presence, absence or
modification of highly conserved structural domains in their encoded proteins (Balczarek et
al., 1997; Hadrys et al., 2005; Vorobyov and Horst, 2006) (Figure 1). Subsequent species
splitting and further gene duplication and modification within each group have resulted in
nine vertebrate Pax genes (Balczarek et al., 1997; Dahl et al., 1997; Kay and Ziman, 1999;
Treisman et al., 1991; Walther and Gruss, 1991; Walther et al., 1991; Ward et al., 1994). Pax
proteins are defined by the presence of a highly conserved N-terminal paired domain and a Cterminal transactivation domain, and may contain a conserved octapeptide encoding region
and a full or partial homeodomain (Figure 2).

Each Pax gene, in response to

spatiotemporally varied environmental cues, produces alternate transcripts which encode
alternate isoforms with distinct DNA binding specificities (Callaerts et al., 1997; Kay and
Ziman, 1999; Vogan and Gros, 1997; Wang et al., 2007; Wang et al., 2006; Ziman et al.,
1997; Ziman and Kay, 1998; Ziman et al., 2001b) and alternate transactivation functions
(Vogan and Gros, 1997; Vogan et al., 1996; Walther and Gruss, 1991).
4

Figure 1.

Diagram depicting the evolution of Pax genes – Pax genes are thought to have

arisen from a single Pax ancestral gene which, through multiple gene duplications and
domain modification, resulted in four homologous Pax genes all containing highly conserved
paired DNA binding domains and may or may not include conserved octapeptide and
variable homeodomain structures. Subsequent species splitting and gene duplication within
groups have produced the nine currently identified vertebrate Pax genes (Adapted from
Balczarek et al., 1997; Hadrys et al., 2005; Vorobyov and Horst, 2006).
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Figure 2. Schematic of the structure of Pax Genes – Pax genes are defined by the presence
of a paired box, which encodes a DNA binding domain containing 128 amino acids, and all
contain a C-terminal transactivation domain. Pax gene subgroups are further differentiated
based on the presence or absence of other structural regions, including a conserved
octapeptide encoding region, and a partial or full DNA-binding homeodomain (60 amino
acids). Further Pax gene diversity is achieved by encoding alternate N- and C-terminal
isoforms with different DNA binding specificities and alternate microRNA regulation.
Differential target gene selection is also varied by individual or combined use of DNA
binding domains, together with spatial and temporal autoregulation, and participation of
requisite co-factors.
6

Diversity of Pax gene function can be achieved using these isoforms by several mechanisms;
individual or combined use of paired- or homeodomains for DNA binding site selection
(Apuzzo and Gros, 2007; Underhill and Gros, 1997); microRNA regulation of 3’ alternate
gene transcripts (Chen et al., 2010; Crist et al., 2009; Dey et al., 2011); alternate proteinprotein interactions (Charytonowicz et al., 2011); alternate DNA binding and transactivation
in the presence of spatiotemporally varied co-factors (as detailed in section 5.2); spatial and
temporal autoregulation (Grindley et al., 1995; Plaza et al., 1999) (Figure 2).

3.

OVERVIEW OF PAX GENES IN CNS DEVELOPMENT

The Pax gene family displays dynamic spatiotemporal expression patterns and, together with
other factors, act to co-ordinate regional CNS development, specifying neural subtypes and
controlling their migration and differentiation. Expression studies and mutant models provide
insight into their multiple developmental roles (Kawakami et al., 1997; Lun and Brand, 1998;
Mansouri et al., 1996; Matsunaga et al., 2000; Nomura et al., 1998; Pfeffer et al., 1998;
Schwarz et al., 1999; Thompson et al., 2007; Thompson et al., 2008). Notably, expression is
not limited to embryogenesis; postnatal and adult expression is commonly observed (Hack et
al., 2005; Kawakami et al., 1997; Kohwi et al., 2005; Kukekov et al., 1999; Maekawa et al.,
2005; Nacher et al., 2005; Nakatomi et al., 2002; Shin et al., 2003; Thomas et al., 2007;
Thompson et al., 2007).

In this review, details of the substantive roles of Pax genes

(specifically Pax2, 3, 5, 6, 7 and 8 •) in CNS development are considered, from cell

•

Pax1 and Pax9 participate in vertebral column, bone, teeth, anterior digestive tract and

thymus development (Gerber et al., 2002; Neubuser et al., 1995; Peters et al., 1998; Wallin et
al., 1996) and Pax4 is expressed in the pancreas (Brun et al., 2004; Collombat et al., 2009),
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specification and regionalisation at early stages (Ericson et al., 1997; Kawakami et al., 1997;
Matsunaga et al., 2001; Nomura et al., 1998; Schwarz et al., 1999; Stoykova and Gruss,
1994) to proliferation, migration and differentiation at later stages (Burrill et al., 1997; ChanLing et al., 2009; Conway et al., 2000; Kohwi et al., 2005; Maekawa et al., 2005; Marquardt
et al., 2001; Talamillo et al., 2003). Throughout development, Pax gene expression holds
subsets of cells in an anti-apoptotic, progenitor state until environmental stimuli dictate
progression to proliferation or differentiation (Berger et al., 2007; Kohwi et al., 2005;
Maekawa et al., 2005; Nacher et al., 2005; Underwood et al., 2007; Yang et al., 2008). The
Pax family are therefore crucial in orchestrating and chaperoning maturing cells throughout
multiple stages of CNS development and maturation.

4.

PAX GENES TO ENHANCE CNS CELL REPLACEMENT THERAPY AND
REPAIR

The ability to transplant replacement cells into the CNS to effect functional repair will
ultimately depend upon knowledge of factors that direct embryonic stem cells along
proliferation and neural differentiation processes to achieve formation and integration into
tissue architecture and circuitry. Conditioning stem cells in vitro for cell replacement may
require an accurate recapitulation of the neural milieu (Baizabal and Covarrubias, 2009), a
difficult task considering the panoply of genes involved in regional CNS development and
their highly dynamic spatiotemporal expression patterns. The accurate use of transcription
factor combinations and concentrations to recapitulate cellular subtype specification would be
extremely difficult to achieve in vitro. Therefore, a key gene at the top of a differential
and whilst they do not participate in CNS development, they direct stem or progenitor cell
specification within organs/tissues in which they are expressed.
8

hierarchy, such as the Pax genes, may well provide a solution to this problem. Furthermore,
repair strategies for pathogenic or traumatic brain/spinal cord injury, or endogenous
degeneration due to stroke/ischaemia, maldevelopment or neurodegeneration, will vary in the
requirement of multiple cell types.

This may be due to primary insult and secondary

sequelae, or the requirement of restricted cell types for definitive cell replacement. The
application of developmental Pax genes to produce a specific cell type or direct desired
differentiation pathways may be beneficial for transplant therapies that require definitive
cellular replacement. Examples include the Pax6-driven trans-differentiation of retinal
pigmented epithelia into neuroretina for visual restoration (Arresta et al., 2005; Azuma et al.,
2005), hair follicle stem cells into corneal epithelial-like cells for corneal repair (Yang et al.,
2009) and reprogramming of postnatal astroglia to a neuronal lineage (Berninger et al., 2007;
Heins et al., 2002). Directed manipulation of a stem cell lineage appears to be an important
step in cell transplantation protocols to reduce the possibility of host- or donor-derived
tumour formation in the recipient (Amariglio et al., 2009; Erdo et al., 2003; Reubinoff et al.,
2001; Thomson et al., 1998). A further consideration is how neuroinflammatory mechanisms
operating within the regenerating tissue environment affect cell survival and maturation after
transplant (reviewed in Jain, 2009; Park et al., 2009). Taken together, these factors will
affect the cell type and/or genetic manipulations required for successful therapeutic strategies.
Whilst the exploitation of Pax transcription factors, or indeed that of any pivotal transcription
factor, has great potential for regenerative purposes, complex and often dosage-dependent
functions will require sophisticated and carefully considered use to ensure a successful
outcome.

In this paper our aim was to evaluate the capacity of Pax genes to enhance CNS

cell replacement therapy and repair. To achieve this aim we first reviewed their
developmental and regenerative capabilities and then assessed their demonstrated efficacy in
cell lineage manipulation experiments drawing from in vivo and in vitro investigations. The
9

results presented below detail Pax gene function in initial regionalisation of the CNS,
precursor cell specification and expansion, proliferation, migration, maintenance, and
subsequent differentiation, and their capacity to withstand a post-insult environment. We
also suggest mechanisms by which Pax genes may concomitantly regulate proliferation, stem
cell maintenance and differentiation along specific cell lines. We took these results, together
with those of recent stem cell replacement experiments, to formulate a considered opinion
about the potential use of Pax genes for stem cell manipulation for CNS cell replacement
therapies.

5.

PAX GENES IN REGIONALISATION OF THE CNS

Pax gene expression occurs at the earliest stages of neural development, during gastrulation
and neural plate formation. During neurulation, anteroposterior and dorsoventral signalling
centres pattern the CNS, culminating in distinct gene expression domains that cause regional
subdivision (Lumsden and Krumlauf, 1996; Redies and Puelles, 2001). Pax genes are key
mediators of this process, differentially responding to signalling molecules (Crossley et al.,
1996; Ericson et al., 1996; Ericson et al., 1997; Fedtsova et al., 2008; Fogel et al., 2008;
Joyner, 1996; Liem et al., 1995; Monsoro-Burq et al., 1996) thus contributing to cell type
specification and brain regionalisation (Burrill et al., 1997; Kawakami et al., 1997; Nomura
et al., 1998; Schwarz et al., 1999; Soukkarieh et al., 2007). Graded Pax expression results
from the spatial proximity of the Pax-expressing cells to the signalling centres and, as will be
discussed later, differential Pax levels contribute to cellular diversity, a mechanism
commonly used during development to produce cell type variation.
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5.1

Dorsoventral Patterning of the CNS

Pax3 and Pax7 are expressed at the dorsal edges of the early neural plate preceding neural
tube closure (Basch et al., 2006; Otto et al., 2006), where they dorsalise cells along the entire
neural tube. Cells of the dorsal neural tube form sensory neurons and interneurons (Goulding
et al., 1991; Jostes et al., 1991), as well as neural crest cells, all of which require Pax3/7
(Auerbach, 1954; Bang et al., 1997; Basch et al., 2006; Goulding et al., 1991; Otto et al.,
2006). Pax6 expression occurs along the entire mid-ventral region of the developing neural
tube, generating motor neurons and interneurons (Goulding et al., 1993). Pax2 expression
within the neural tube occurs at the intermediate dorsoventral boundary of the
rhombencephalon and spinal cord (Nornes et al., 1990), producing hindbrain and spinal cord
interneurons (Burrill et al., 1997; Ponti et al., 2008).

5.2

Anteroposterior Patterning of the CNS

Highly specific Pax-directed anterior-posterior patterning during regionalisation of the
developing CNS has been demonstrated by expression and transgenic studies for multiple
Pax genes (Kawakami et al., 1997; Matsunaga et al., 2000, 2001; Nomura et al., 1998;
Schwarz et al., 1999; Stoykova and Gruss, 1994). Initially, differential Pax6 and Pax2
expression subdivides the neural tube into three primary anteroposterior domains
(prosencephalon, mesencephalon and rhombencephalon) (Matsunaga et al., 2000; Nornes et
al., 1990; Schwarz et al., 1999). Subsequent to this, and as detailed in Table 1, the repressive
relationship between Pax genes, or between Pax and other genes, participates in
determination of polarity, boundary formation and progenitor cell specification from
ventricular zones (VZ) within these regions to form brain nuclei and associated structures.
The ability of Pax genes to mutually repress expression of alternate group Pax genes leads to
zones of exclusivity for each Pax gene or group of Pax genes (Table 1). Pax proteins may
11

also cooperate with other transcription factors (eg opposing gradients of Pax6 and Emx2 or
Pax6 and Dlx2 in cerebral cortex, and Pax6 and Olig2 in olfactory bulb/Pax6 with cVax and
Tbx5 in retina) to achieve specification of cellular subtypes, boundary formation and
arealisation (Bishop et al., 2000; Brill et al., 2008; Hack et al., 2005; Hamasaki et al., 2004;
Leconte et al., 2004; Muzio and Mallamaci, 2003).

Complex Pax activity is highly co-ordinated to achieve differential regulatory mechanisms at
different times and in different locations. For instance, the co-operative and redundant
activity of Pax6 and Pax2 specifies retinal pigmented epithelia at early optic vesicle stages
(Baumer et al., 2003) whilst they are mutually repressive at later optic cup stages (Baumer et
al., 2002; Schwarz et al., 2000). Correspondingly, mutual co-ordinated repression between
Pax6 and Pax2/5/8 regulates development of spinal cord interneurons (Bel-Vialar et al.,
2007; Burrill et al., 1997; Pillai et al., 2007). Moreover, Pax3 and Pax7 co-ordinate
neurogenesis within the midbrain, evidenced by altered Pax3 expression in Pax7-/- mutant
mice (Thompson et al., 2008), and Pax7 upregulation in Pax3 hypomorphic mice (Zhou et
al., 2008). Thus, synchronous and highly co-ordinated Pax expression is critical for
stipulating early patterning processes during CNS development.
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Table 1. Differential Pax expression during anteroposterior patterning.

Region

Pax
Gene

Expression and Potential Function

Pax2

Forebrain/midbrain boundary (with En-1)
(opposes Pax)
Specification of precursor cells of the
forebrain, eye field, otic vesicle

(Matsunaga et al., 2000;
Schwarz et al., 1999)
(Fotaki et al., 2008; Nornes et
al., 1990; Torres et al., 1996)

Pax7

Forebrain/midbrain boundary formation
(opposes Pax2)
Specification of cortical progenitors, and
cortical arealisation (opposes Emx2)
Specification of neural plate cells of the eye
field/dorsoventral patterning of the retina
Specification of hypothalamic progenitor cells

Pax
2/5/8

Midbrain/hindbrain boundary formation and
polarisation regulated by the isthmic organiser

(Matsunaga et al., 2000;
Schwarz et al., 1999)
(Bishop et al., 2000; Gotz et
al., 1998)
(Leconte et al., 2004; Zaghloul
and Moody, 2007)
(Ohyama et al., 2008)
(Brand et al., 1996; Lun and
Brand, 1998; Pfeffer et al.,
1998; Picker et al., 1999;
Rowitch and McMahon, 1995)

Forebrain
Pax6

Pax6
Pax
3
Midbrain

Pax7

Expressed in ventral embryonic midbrain and
adult dorsolateral substantia nigra reticularis
Specification of the dorsal mesencephalon and
is restricted to undifferentiated mesencephalic
cells after boundary formation
Specification of the dorsal mesencephalon, and
is expressed in undifferentiated and
differentiated (neuronal) mesencephalic cells
after boundary formation
Polarisation of the dorsal mesencephalon

References

(Stoykova and Gruss, 1994)
(Matsunaga et al., 2001;
Stoykova and Gruss, 1994;
Thompson et al., 2008)
(Kawakami et al., 1997;
Matsunaga et al., 2001;
Nomura et al., 1998; Stoykova
and Gruss, 1994; Thompson et
al., 2007; Thompson et al.,
2008)
(Thomas et al., 2007;
Thompson et al., 2007)
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Pax
2/5/8

Hindbrain

Pax6

Pax3

Pax7

Spinal
Cord

Pax2

Pax6

Participates in midbrain/hindbrain boundary
formation
Specification and differentiation of
GABAergic interneurons
Expressed in mouse ventricular zone and
external germinative layer. Controls
differentiation and proliferation of motor
neurons and ventral interneurons from ventral
progenitors
Specifies rhombomeric caudal neural crest
cells Expressed in ventricular zone of mouse
hindbrain
Specifies rhombomeric caudal neural crest
cells. Expressed around Purkinje cells
(cerebellum) – may relate to maintenance of
normal physiology
Specification and maintenance of GABAergic
cells of dorsal horn interneurons (inhibiting
Pax6)
Development of spinal interneurons (inhibiting
Pax2/5/8)

(Brand et al., 1996; Lun and
Brand, 1998; Pfeffer et al.,
1998; Picker et al., 1999;
Rowitch and McMahon, 1995)
(Maricich and Herrup, 1999)

(Ericson et al., 1997; Stoykova
and Gruss, 1994)

(Goulding et al., 1991;
Mansouri et al., 1996;
Stoykova and Gruss, 1994)
(Mansouri et al., 1996; Shin et
al., 2003; Stoykova and Gruss,
1994)
(Bel-Vialar et al., 2007; Burrill
et al., 1997; Pillai et al., 2007)
(Bel-Vialar et al., 2007; Burrill
et al., 1997; Pillai et al., 2007)

The critical importance of Pax genes in regionalisation and cellular specification is
exemplified by mutant animal models, where absence of Pax transcription factors results in
patterning abnormalities and loss of cells and structures (Table 2).

Moreover, conditional mutant models (knockout/reduced/overexpression) have allowed an
intricate dissection of Pax function at variable stages of development, without initial ablation
of structures, lack of initial proliferation or lethality issues. It is evident that analyses of
such valuable animal models will permit a deeper understanding of the temporospatial
influence of Pax genes during various stages of development (Manuel et al., 2007; Marquardt
et al., 2001; Pinon et al., 2008; Tuoc et al., 2009), and they demonstrate the requisite nature
of Pax genes in correct cellular specification and patterning.
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Table 2. Patterning and structural abnormalities in Pax mutant animal models.
Pax
Gene
Pax2

Pax5
Pax6

Patterning and structural abnormalities
Loss of the isthmus; failure to close the midbrain neural tube,
abnormalities of the midbrain/hindbrain region
Visual defects; alteration to the optic nerve projection and
formation of the retina/optic nerve boundary; agenesis of the optic
chiasm and failure to close the optic fissure
Auditory defects; abnormal epithelial morphogenesis producing
defects of the cochlear and spiral ganglion of the inner ear
Midbrain defects; reduction of the inferior colliculus
Hindbrain defects; altered foliation of the anterior cerebellum
Cortical defects; Thalamocortical and corticofugal axonal
pathfinding errors in Pax6 null mutants; no evidence in Pax6
conditional knockout/overexpression models
Cortical layering abnormalities and premature differentiation of
late-born cortical progenitors; ventralisation of dorsal
telencephalic progenitors in Pax6 null mice with subsequent
ectopic GABA interneuron formation

Visual defects; Microphthalmia (Pax6 over-/under-expression) or
anophthalmia (absence of Pax6); dorsalisation of the retina (Pax6
overexpression), ventralisation of the retina (absence of Pax6)

Pax2/
Pax6#
Pax3

Pax7

Pax3/
Pax7#

Craniofacial defects; Required for differentiation of nasal
placodes; Pax6 null mice exhibit an imperforate snout
Visual defects; Transdifferentiation of retinal pigmented
epithelium into neuroretina
Neural tube defects; Open neural folds, neural tube irregularities
and exencephaly (Embryonic lethal)
Neural crest defects; Cardiac defect - conotruncal defect due to
reduction in migratory cardiac neural crest cells
Midbrain defects; Failure to maintain a subpopulation of dorsal
mesencephalic neurons
Craniofacial defects; Absence of nasal capsule and reduction in
maxilla and tubules of nasal serous glands due to aberrant neural
crest cell specification
Neural tube and spinal cord defects; extensive
exencephaly/spina bifida/ventralisation of dorsal spinal cord
interneurons (Embryonic lethal)

References
(Brand et al., 1996;
Torres et al., 1996)
(Torres et al., 1996)
(Christophorou et al.,
2010; Torres et al.,
1996)
(Urbanek et al., 1994)
(Jones et al., 2002;
Kawano et al., 1999;
Kroll and O'Leary,
2005; Manuel et al.,
2007; Pinon et al.,
2008; Pratt et al., 2000;
Pratt et al., 2002; Tuoc
et al., 2009)
(Baumer et al., 2002;
Hill et al., 1991; Hogan
et al., 1986; Leconte et
al., 2004; Manuel et
al., 2007)
(Hill et al., 1991;
Hogan et al., 1986)
(Baumer et al., 2003)
(Auerbach, 1954)
(Conway et al., 2000)
(Thompson et al.,
2008)
(Mansouri et al., 1996)

(Mansouri and Gruss,
1998)
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6.

PAX GENES IN PROGENITOR CELL EXPANSION AND MAINTENANCE

After brain regionalisation, the contribution of Pax genes to the intricate balance between cell
proliferation, progenitor cell maintenance and differentiation (and therefore in CNS growth
and development) has been demonstrated by substantial research.

For instance, Pax6 controls progenitor pool expansion, often in a dosage-dependent manner,
in developing regions such as the optic vesicle (Duparc et al., 2007), the cerebral cortex
(Berger et al., 2007; Estivill-Torrus et al., 2002; Sansom et al., 2009; Tuoc et al., 2009) and
the postnatal hippocampus (Maekawa et al., 2005; Nacher et al., 2005). Within the eye field
Pax6 similarly promotes proliferation of retinal stem cells, expanding the proliferative pool
from early optic vesicle stages and throughout multiple stages of retinogenesis (Xenopus)
(Zaghloul and Moody, 2007). Reduced Pax6 levels lead to reduced proliferation and/or
precocious differentiation of neurogenic precursors in the eye (Duparc et al., 2007; Philips et
al., 2005), cerebral cortex (Tuoc et al., 2009) developing spinal cord (Bel-Vialar et al.,
2007), and reduced proliferation in the postnatal hippocampus (Maekawa et al., 2005). In
contrast, overexpression of Pax6 reduces proliferation of late-born cortical progenitors,
demonstrating the differential dosage sensitivity of this cellular subpopulation (Tuoc et al.,
2009).

These results demonstrate that Pax6 levels mediate the critical spatiotemporal

orchestration of progenitor cell proliferation and differentiation to produce precise CNS
regions.

Likewise, Pax3 is also necessary for progenitor expansion and for maintenance of the
undifferentiated phenotype. Premature neurogenesis is observed at E10.0 in the lumbar
neural tube of Pax3-/- mice and in the neural tube explant cultures from these mice (Nakazaki
et al., 2008); moreover, Pax3 expression within the developing superior colliculus (dorsal
16

mesencephalon) is restricted to undifferentiated neural precursor cells and disappears once
the cells differentiate (Thompson et al., 2008). In cultured mouse neuroblastoma cells,
downregulation of Pax3 by antisense RNA leads to differentiation of cells into mature
neurons (Reeves et al., 1999). Similarly, neural crest cell development provides an exquisite
example of the capacity of Pax3 to regulate progenitor cell expansion and maintenance of an
undifferentiated phenotype. Pax3-expressing neural crest cells initially arise in the dorsal
neural tube. Once committed by a number of transcription factors, including Pax3, along
Schwann as well as melanocytic or cardiac lineages, the cells proliferate and migrate as
undifferentiated cells to populate the peripheral nervous system (Schwann cells) (Kioussi et
al., 1995), skin (melanocytes) (Bang et al., 1997; Blake and Ziman, 2005; Goulding et al.,
1991; Hornyak et al., 2001), and heart (cardiac) (Conway et al., 2000). Pax3 is expressed
throughout their specification, migration and differentiation. In fact neural crest cell-derived
precursors require Pax3; in Pax3-/- mice these cells undergo normal migratory and survival
functions but have reduced progenitor expansion resulting in developmental defects (Conway
et al., 2000). Pax7 also specifies a subpopulation of mouse cephalic neural crest cells that
migrate to the craniofacial region (Mansouri et al., 1996) and eventually give rise to a wide
variety of olfactory epithelial cell types (Murdoch et al., 2010). Similarly, Pax7-/- mutant
mice exhibit craniofacial abnormalities (Mansouri et al., 1996).

Interestingly, whilst Pax3

expression occurs in both premigratory and migrating neural crest cells, Pax7 expression is
restricted to migrating neural crest cells (Betters et al., 2010), indicating divergence during
early (premigratory) functions.

One mechanism by which Pax proteins control progenitor expansion and maintenance
involves their regulation of distinct downstream targets, for example cell cycle regulators.
Pax3 activates progenitor expansion within the neural tube and forebrain by activating Hes1,
17

which represses p21cip, a cell cycle regulator known to promote quiescence of neural
progenitor proliferation (Kippin et al., 2005; Nakazaki et al., 2008). Moreover, Hes1/Hes3
compound mutant mice phenocopy Pax2/Pax5 mutant mice (absence of midbrain and
anterior hindbrain structures), with premature termination of Pax2/5/8 expression, and loss of
isthmic organiser activity, due to an inability to maintain isthmic ventricular cells. This lack
of progenitor maintenance results in premature neuronal differentiation, a common feature of
downregulated Pax expression. This result together with other studies suggests a regulatory
relationship between Hes1/3 and Pax2/5/8 genes to bring about a delay in the neurogenesis of
isthmic cells, thereby maintaining isthmic organiser activity (Hirata et al., 2001).

Notably, the ability of Pax transcription factors to bind to cell cycle regulators, thus
controlling proliferation versus differentiation, is also demonstrated by direct binding of Pax6
to genes involved in stem cell self-renewal (eg Hmga2), cell cycle progression and
proliferation (e.g. Pten and cyclin-dependent kinases (Cdk4)), neuronal cell cycle inhibition
(Hes5/6), and neuronal differentiation (Ngn2) (Sansom et al., 2009; Scardigli et al., 2003).
These results identify some of the mechanisms and downstream targets whereby Pax genes
regulate the switch from cell proliferation to differentiation.

7.

PAX GENES IN CELLULAR MIGRATION

A key feature of organogenesis is the orchestrated temporospatial migration of cells, which
appears to be of pivotal importance for conditional specification of correct cellular
subclasses. Pax genes contribute extensively to cellular migration, as shown in Table 3.
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Table 3: Examples of Pax–expressant neural migratory cells
Pax Gene

Pax2

Pax6

Migrating population/tissue
Expressed in precursor and immature astrocytic
cells migrating within the retina, and in
migrating interneurons of the postnatal
cerebellum and ventral spinal cord
Expressed in migrating neuronal precursors,
neurons and interneurons within the developing
cerebrum and medulla oblongata, and adult
cerebellum
Expressed in migrating neuroblasts within adult
neurogenic regions of the dentate gyrus of the
hippocampus and rostral migratory stream to the
olfactory bulb
Adult rat spinal cord after trauma

References

(Burrill et al., 1997; Chan-Ling
et al., 2009; Ponti et al., 2008)
(Caric et al., 1997; Horie et al.,
2003; Jimenez et al., 2002; Mo
and Zecevic, 2008; Ponti et al.,
2008; Talamillo et al., 2003)
(Hack et al., 2005; Kohwi et al.,
2005; Maekawa et al., 2005;
Nacher et al., 2005)
(Yamamoto et al., 2001)

Pax3

Neural crest cells migrate to cephalic
mesenchyme, skin, peripheral nervous system
and heart

(Betters et al., 2010; Conway et
al., 2000; Goulding et al., 1991;
Hornyak et al., 2001; Kioussi et
al., 1995)

Pax7

Neural crest cells migrate to craniofacial
regions, and neuroblasts migrate within the
midbrain to form the laminated structure of the
superior colliculus

(Betters et al., 2010; Mansouri
et al., 1996; Murdoch et al.,
2010)

For instance, Pax3-expressing neural crest cells migrate extensively throughout the body and
Pax-3 deficiency results in altered migration or reduced cells at the target destination
(Hornyak et al., 2001; Nakazaki et al., 2008).

Pax6 is also required for correct cellular

migration in some cell populations, and Pax6-deficiency can result in altered migration of
neuroblasts in the developing mouse cerebral cortex (Jimenez et al., 2002; Talamillo et al.,
2003) and in the medullary cerebellum (Horie et al., 2003). A reduction of cells at the target
destination, however, may not always be due to a migratory deficit, but rather a failure to
adequately expand the progenitor pool. Moreover, expression during migration does not
necessarily infer causality in this process; it may be that Pax gene expression is required for
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maintaining progenitor status during migration to provide cells for proliferation at new
organs/tissue.
Evidence of a role for Pax proteins in influencing migratory capacity can be discerned from
their interactions (direct or indirect) with genes such as cellular adhesion molecules, and this
feature is also differentially affected by alternate isoforms acting on distinct downstream
targets (Wang et al., 2008; Wang et al., 2007; Zhang et al., 2010). Pax paired box DNA
binding sites have been discovered in the promoters of several neural cell adhesion molecules
(neural cell adhesion molecule (N-CAM), neuron-glia cell adhesion molecule (Ng-CAM) and
L1). Transfection experiments in a variety of cell lines show that these sites are regulated by
Pax1, Pax3, Pax6 and Pax8 (Edelman and Jones, 1998); Pax6 has also been shown to regulate
expression of L1 in vivo (Meech et al., 1999) and L1 expression is abnormal in Pax6-/- mice
(Caric et al., 1997). Maekawa et al (2005) also demonstrated colocalised expression of Pax6
and polysialylated N-CAM (PSA-NCAM) in cells of the postnatal rat dentate gyrus.
Furthermore, Wang et al (2008) detected upregulated Met and Muc18 (mRNA and protein) in
melanocytes transfected with the Pax3c isoform. Pax3 also regulates c-Met during muscle
precursor migration (Epstein et al., 1996; Mayanil et al., 2001), and increased polysialylation
of N-CAM due to Pax3 overexpression is observed in a medulloblastoma cell line (Mayanil
et al., 2000).

Discernment of the cell-autonomous and non-autonomous contribution of Pax genes to
migratory capacity has been achieved through transplantation of Pax-deficient cells into a
normal host environment, and vice versa (Kohwi et al., 2005; Osumi-Yamashita et al., 1997).
Unambiguous identification of a Pax role in non-cell-autonomous migration comes from
studies where midbrain-derived neural crest cells (which do not express Pax6) do not migrate
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appropriately to the eye (Kanakubo et al., 2006) and craniofacial region (Osumi-Yamashita et
al., 1997) in Pax6-deficient rats. Transplantation of midbrain-derived neural crest cells from
wildtype rats into the Pax6-deficient environment does not rescue migration, indicating that
the fault occurs due to an incorrectly specified migratory pathway and not due to deficits in
the migrating cell (Osumi-Yamashita et al., 1997). In support of this, Pax6-/- late born
cortical precursor cells transplanted into a wildtype environment showed similar migratory
capacity to wildtype cells, indicating that Pax6 does not bestow a cell-autonomous migratory
capacity to the cell in this instance (Caric et al., 1997).

Pax genes also contribute to migratory processes within a developing tissue, such as in axon
guidance (Jones et al., 2002; Kanakubo et al., 2006; Kawano et al., 1999; Osumi-Yamashita
et al., 1997; Pratt et al., 2002). During cortical development, progenitors from the SVZ
migrate to their appropriate destination, using PSA-NCAM and robo2 as guidance molecules.
Pax6 mutant mice exhibit qualitative changes to PSA-NCAM+ tracts within the intermediate
zone, disrupted (delayed and downregulated) expression of robo2 and subsequent migratory
deficits (Jimenez et al., 2002). Moreover, Pax6-expressing cells of the foetal rat medulla
oblongata associate with the neural cell adhesion molecule TAG1, and migrate along TAG1expressing axons.

In this region of Pax6-/- rats, TAG1 expression is delayed and a

subpopulation of these cells migrate aberrantly (Horie et al., 2003). Within the rostral
migratory stream, Pax6-positive neuroblasts migrate tangentially toward the olfactory bulb,
whereby migration halts, neuroblasts detach and then migrate radially to the olfactory bulb.
Tenascin-R is an extracellular matrix molecule which fosters neuroblast detachment and
radial migration; tenascin-R-deficient mice exhibit altered migration of olfactory neuroblasts
(Saghatelyan et al., 2004). Biochemical evidence of a direct relationship between Tenascin-R
and Pax proteins during migration, however, has not been demonstrated to date.
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Pax2 regulation of the cellular adhesion molecules N-CAM and N-cadherin, although more
related to morphogenesis than migration, is also elegantly demonstrated in investigation of
chick otic development; morpholino knockdown of Pax2 results in absence of the above
named molecules, whilst Pax2 overexpression results in their upregulation, and ectopic Pax2
induces their expression (Christophorou et al., 2010).

This review of Pax endowment of migratory capacity, whilst not exhaustive in nature,
indicates a complex contribution of Pax genes towards directed migration of cells in both
embryonic and postnatal environments. This feature may be manipulated to deliver cells to
an appropriate destination, or to block migration of transplanted cells.

8.

PAX GENES IN CELL FATE SPECIFICATION

After CNS regionalisation, Pax expression becomes increasingly restricted as cellular
specification proceeds. In fact a recognised feature of Pax genes is their ability to act as a
functional switch between progenitor maintenance and differentiation. For example, as eye
development progresses, Pax6 functions to switch neuroepithelial cells of the mouse optic
vesicle from proliferation towards differentiation. At this stage (E9.5), Pax6 negatively
regulates proliferation by repressing regulators of cell cycle progression (eg p21cip1, p27kip1,
p57Kip2) thus switching the focus towards progression and differentiation of the developing
eye structure (Duparc et al., 2007).

Accordingly, Pax6-/- mice at this time exhibit

overproliferation of optic vesicle precursor cells (Duparc et al., 2007).

At later stages of eye development (E13.5), conditional gene targeting of Pax6 demonstrated
its ability to activate neuronal-specific genes such as Math5, Mash1 and Ngn2 at appropriate
times, culminating in precise specification of multiple neuronal subtypes (Marquardt et al.,
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2001). Accordingly, increasing or decreasing Pax6 expression during early Xenopus eye
field development increases or decreases retinal stem cell proliferation, respectively, and
changes the differentiation profile of the retinal subtypes. However, the effect of altered
Pax6 levels on proliferation is weakened in the mature retina, reflecting a functional switch
from proliferation in early stages towards differentiation at later stages (Zaghloul and Moody,
2007). These results also implicate the involvement of distinct co-factors (both upstream and
downstream) in the cellular response to Pax regulation.

This capacity of Pax6 to invoke a temporally-sensitive switch from proliferation to
differentiation within the retina parallels Pax6 function elsewhere in the CNS.

During

cerebrocortical development, the absence of Pax6 in conditional knockout mice results in
overproliferation of early precursors and premature cell cycle exit (Estivill-Torrus et al.,
2002) with depletion of the progenitor pool available for late neurogenesis (Tuoc et al.,
2009). Conversely, overexpression of Pax6 reduces proliferation of late cortical progenitors
in a cell-autonomous and auto-regulated manner (Manuel et al., 2007). Furthermore, Pax6deficient embryonic stem cells transplanted into the dorsal telencephalon of the developing
chick give rise to misspecified progenitors that generate GABAergic rather than
glutamatergic neurons (Nikoletopoulou et al., 2007).

Similarly, in adult neurogenesis, altered levels of Pax6 in the rat hippocampus cause
precocious progression of early progenitor cells to late stages (Maekawa et al., 2005) or
precocious differentiation into neuronal subclasses.

This feature also exists within the

developing spinal cord, where variable Pax6 levels are responsible for different functional
outcomes; initially Pax6 promotes proliferation, then an increase in Pax6 within the cells of
the ventricular zone invokes a switch determining cell cycle exit and cessation of
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proliferation. Conversely, low levels of Pax6 favour maintenance of the progenitor state. In
the developing spinal cord of Pax6-/- mice, loss of Pax6 leads to premature differentiation of
neural precursor cells (Bel-Vialar et al., 2007) and similarly causes precocious
oligodendrogenesis and astrogenesis (Sugimori et al., 2007). Under these circumstances,
inappropriate neurons/glia may be formed due to differentiation in an incorrect environment
and/or at the incorrect time (Hack et al., 2005; Kohwi et al., 2005; Philips et al., 2005;
Sugimori et al., 2007), or there may be cell loss secondary to disrupting either the intricate
balance between proliferation and differentiation (Kohwi et al., 2005), or the relationship
between the differentiating cell and its environment. An example of the latter occurs when
precocious neurons formed in the rudimentary optic vesicle in Pax6-/- mice fail to persist
(Philips et al., 2005), indicating the pivotal relationship between the cell, the
microenvironment, and the correct timing of differentiation.

Another illustrative example is the directed differentiation within the SVZ/olfactory bulb
system whereby Pax6 expression is maintained in a subset of adult SVZ progenitors which
migrate to the olfactory bulb, where Pax6 is downregulated and progenitors differentiate,
producing the appropriate neuronal subclass. Although Pax6-/- progenitors transplanted into
the SVZ of adult wildtype mice produce progenitor cells capable of correct migration, they
undergo precocious differentiation and fail to generate particular subsets of neurons (Kohwi
et al., 2005).

Interestingly, Pax6 is not required for generation of dopaminergic

periglomerular neurons during development (Mastick and Andrews, 2001), in contrast to its
requisite role during their formation in adult neurogenesis (Brill et al., 2008), providing
another example of a highly complex cellular control based upon temporal variance.
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So, differential regulation of/by Pax6 provides the capacity for progenitor proliferation,
maintenance, cell cycle progression and neurogenesis driven by variable Pax6 protein levels
(Berger et al., 2007; Manuel et al., 2007; Sansom et al., 2009; Tuoc et al., 2009). This
capacity may also be affected by isoform variants, as the canonical (full-length) Pax6 protein
regulates cell fate and proliferation, whilst the Pax6(5a) variant (binding of the PAI of the
paired domain is abolished) regulates cell proliferation only during mouse CNS development
(Haubst et al., 2004), indicating distinct downstream targets for these functions. Similarly,
the full-length Pax6 protein is present in the sub-ependymal zone and olfactory bulb, whereas
the PD-less isoform (paired-less; lacks entire paired domain) is only present in the olfactory
bulb, where it complexes with the full-length Pax6 protein to regulate neuronal survival via
homeodomain-mediated DNA binding of crystallin-αA (Ninkovic et al., 2010). Thus a
complex spatial and temporal Pax6 isoform profile is required during development for correct
specification of neuronal subtypes.

The temporally-driven command of progenitor maintenance versus differentiation is also a
recognised feature of other Pax proteins. Pax3, for example, at early stages maintains the
undifferentiated phenotype of neural crest cells, but at later stages Pax3 binds directly to cisregulatory elements in the promoter of Ngn2 and thus may initiate differentiation of the
neuronal lineage in the neural tube (Nakazaki et al., 2008). Within the ophthalmic trigeminal
placode, Pax3 activation is required for neuronal differentiation to occur; however,
misexpression of Pax3 in head ectoderm results in upregulation of proneural genes (eg Ngn2)
without neuronal differentiation occurring, indicating a tissue-specific regulation for Pax3 in
neuronal differentiation (Dude et al., 2009). This tissue-specific regulation is mediated
perhaps by spatially restricted co-factors and/or by alternate isoforms (Charytonowicz et al.,
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2011; Lamey et al., 2004; Vogan and Gros, 1997; Ziman et al., 1997; Ziman and Kay, 1998;
Ziman et al., 2001b).

To add further complexity, co-ordinated expression of multiple Pax genes may be required
for correct development and definitive cell determination, such as the co-operative expression
of Pax6 and Pax2 during CNS boundary formation. Another classic example of this coordinated expression occurs within the developing eye. At early optic vesicle stages, the coordinated and redundant activity of Pax6 and Pax2 specifies the retinal pigmented epithelia
(Baumer et al., 2003). Divergent expression patterns at slightly later stages of optic cup
morphogenesis determine the interface between the retina (Pax6-positive) and optic nerve
(Pax2-positive), delineated by mutual Pax6/Pax2 repression, thought to be achieved via the
late retinal α-enhancer in the promoter of Pax6, which is repressed by Pax2 (Baumer et al.,
2002; Schwarz et al., 2000). This mutual repression results in spatially and functionally
distinct populations of cells (Schwarz et al., 2000) - Pax6-positive retinal precursor cells
(Marquardt et al., 2001) and Pax2-positive optic nerve astrocytes. Experimental inhibition of
Pax2 in embryonic mouse optic nerve explants causes upregulation of ectopic Pax6
expression and ectopic neuronal differentiation (Soukkarieh et al., 2007). Similarly, within
the developing spinal cord Pax2 maintains Lhx1/Lhx5 and Pax5/8 expression in dorsal horn
interneurons for correct neuronal specification (Pillai et al., 2007). Within the ventral spinal
cord, Pax2 expression is initiated as cells become postmitotic and migrate laterally to the
mantle zone. Preceding this, Pax6 is required to initially specify these neural precursors prior
to postmitotic emergence of neurons and does so by regulating expression of Pax2 and other
neuronal genes. Therefore, co-ordinated Pax6 and Pax2 expression co-operate to correctly
specify ventral interneuron identity (Burrill et al., 1997).

26

Taken together, Pax genes maintain the undifferentiated cellular phenotype, and they
participate in the timely decision to exit the cell cycle, and thus regulate differentiation to
appropriate cell types based upon spatiotemporally permissive conditions, and, in some cases,
co-operation between Pax family members and/or other co-factors.

Identifying the

mechanism underpinning the change in Pax function from proliferation to maintenance of the
progenitor status to differentiation is a key challenge in deciphering Pax function from a
regenerative perspective.

It is likely to involve spatially regulated co-factors, as well as

spatially regulated expression of alternate Pax isoforms, particularly those that involve
modification of the C-terminus (Blake and Ziman, 2005; Charytonowicz et al., 2011; Wang
et al., 2008; Wang et al., 2007; Wang et al., 2006) or regulation of the C-terminus by
microRNAs (Chen et al., 2010; Crist et al., 2009; Dey et al., 2011). These alternate isoforms
may function differentially by regulating different downstream target genes (Charytonowicz
et al., 2011; Vogan and Gros, 1997; Wang et al., 2007; Ziman et al., 1997; Ziman and Kay,
1998; Ziman et al., 2001a; Ziman et al., 2001b).

Thus, Pax genes are critical factors

involved in progressing the spectrum of development from initial progenitor expansion and
maintenance to correct neural differentiation (Bel-Vialar et al., 2007; Berger et al., 2007;
Estivill-Torrus et al., 2002; Lang et al., 2005; Nakazaki et al., 2008; Sansom et al., 2009;
Sugimori et al., 2007). Collectively, these results also highlight an important feature of Pax
genes - their ability to act as multipotent, spatiotemporally-programmed switches which are
sensitive to environmental cues (Gerber et al., 2002). It will be challenging to recapitulate
this feature in the quest for “designer” cells for replacement purposes, and success will
essentially rely on deciphering the genetic/epigenetic environmental factors involved in
discriminating Pax function at different temporal and spatial levels of development.
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9.

POSTNATAL EXPRESSION PATTERNS OF PAX GENES

In addition to their well-accepted role in embryogenesis, the expression of Pax genes in adult
regions is significant (Table 4), being required for maintenance of a progenitor cell phenotype
(such as Pax6 in adult neurogenesis) or for maintenance of plasticity in mature neurons in
response to environmental stimuli (Gerber et al., 2002). Conversely, the absence of Pax6 in
postnatal astrocytes reduces their neurogenic potential (Heins et al., 2002).

Additionally,

Pax6 regulates survival of dopaminergic periglomerular neurons by inhibiting programmed
cell death in these mature olfactory neurons (Ninkovic et al., 2010).

Table 4: Postnatal expression patterns of Pax genes
Pax
Gene

Adult animal cells showing Pax expression

References

GABAergic cerebellar interneurons (rabbit)

(Ponti et al., 2008)

Nuclei of the midbrain, pons/medulla and cerebellum
(mouse)

(Stoykova and Gruss, 1994)

Retinal cells, telencephalon, diencephalon, ventral
mesencephalon, cerebellum and pons/medulla
(various mammalian species)

(Nacher et al., 2005; Stanescu
et al., 2007; Stoykova and
Gruss, 1994)

Neural progenitor cells of the SVZ/rostral migratory
stream/olfactory bulb, the subgranular zone of the
dentate gyrus of the hippocampus and the adult
piriform complex

(Guo et al., 2010; Hack et al.,
2005; Kohwi et al., 2005;
Maekawa et al., 2005; Nacher
et al., 2005; Yamamoto et al.,
2001)

Pax3

Bergmann glia and cells surrounding Purkinje cells
of the cerebellum (mouse)

(Stoykova and Gruss, 1994)

Pax7

Superior colliculus, specific nuclei of the
pons/medulla and thalamus; cerebellar Bergmann
glia (rat, mouse and chick)

(Shin et al., 2003; Stoykova
and Gruss, 1994; Thomas et
al., 2007; Thompson et al.,
2007; Thompson et al., 2008)

Pax2

Pax6
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10.

PAX EXPRESSION SUBSEQUENT TO NEUROTRAUMA

One important aspect of neuroscience research is the quest for factors that influence the
capacity for a cell to survive neurotrauma or neurodegeneration and/or the subsequent
neuroinflammatory processes that ensue, and such discoveries will have a major impact on
CNS cell therapy interventions. Whilst there is paucity of information regarding Pax genes
in this regard, several studies have demonstrated the capacity for Pax genes to respond to
neurotrauma and for cells expressing Pax to tolerate the post-insult environment.

Tonchev et al have demonstrated the capacity for newly-born Pax6-expressing neural
progenitors to survive long term in both the subgranular zone (SGZ) of the hippocampal
dentate gyrus (Tonchev and Yamashima, 2006) and the anterior SVZ (Tonchev et al., 2006)
after experimentally-induced transient global cerebral ischemia in primates, reinforcing that
Pax6-expressing progenitors originating from the germinal zones are protected by Pax6
expression. Similarly, Pax-expressing cells withstand injury in various tissues; Pax6- and
Pax7-expressing cells remain within the injured adult rat spinal cord (Yamamoto et al.,
2001), whereas Pax6 expression is upregulated in postnatal olfactory epithelium (Guo et al.,
2010) and re-expressed within retinal cells, including Müller glia (Bernardos et al., 2007;
Fischer and Reh, 2001; Hitchcock et al., 1996; Karl et al., 2008) after lesion.

Similarly, Pax7 is re-expressed in adult rat superior collicular neurons after optic nerve
transection (Thomas et al., 2007); this may reflect an effect of reduced input. Moreover,
increased numbers of Pax7-expressing cells were detected caudally after lesion to the rostralmedial superior colliculus, and expression remained elevated over a four week period
(Thomas et al., 2009). Taken together, these results indicate the capacity for Pax-expressant
cells to survive environmental influences occurring post-insult. It is likely that survival
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capacity may be differentially affected by distinct modes of injury. More work will be
required to definitively assess the capacity of Pax genes to protect cells after trauma or in
degenerating or inflammatory environments. Such knowledge will assist in delivering a
functional, mature cell able to survive the transplanted environment after trauma or
degeneration.
11.

CURRENT STEM CELL THERAPY STRATEGIES FOR CNS REPAIR AND
PAX GENES – GETTING IT RIGHT

Stem cell research is a dynamic area of investigation which harbours great promise for
alleviation of neurological conditions.

To date, transplant therapies have shown some

success in patients and animal models of spinal cord injury (Amoh et al., 2008; Hu et al.,
2010), stroke (Borlongan et al., 1998; Hodges et al., 1996; Sorensen et al., 1996),
Parkinson’s disease (Falkenstein et al., 2009; Kordower et al., 1995; Thompson et al., 2009),
Huntington’s disease (Capetian et al., 2009; Deckel et al., 1983; Freeman et al., 2000) and
retinal disorders (Radtke et al., 2008; Radtke et al., 2004). When used in these scenarios
transplanted cells can survive (Hu et al., 2010), migrate (Bjugstad et al., 2008; Wernig et al.,
2004), integrate (Bjugstad et al., 2008; Borlongan et al., 1998; Sorensen et al., 1996) and
produce some functional benefits (Deckel et al., 1983; Isacson et al., 1984; Pritzel et al.,
1986; Wictorin et al., 1990).

The use of fetal tissue transplants initially provided some

promising results in patients with Parkinson’s disease (Kordower et al., 1995) and
Huntington’s disease (Bachoud-Levi et al., 2000; Gaura et al., 2004) but has been
unfavourably impacted by treatment side effects such as dyskinesias in Parkinson’s disease
(Freed et al., 2001; Greene et al., 1999), and disease-like states occurring within the grafted
cells, causing eventual graft degeneration in Huntington’s disease (Cicchetti et al., 2009) and,
to a lesser extent, in Parkinson’s disease (Kordower et al., 2008a; Kordower et al., 2008b; Li
et al., 2008).
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It is evident that developmental genes involved in key cellular processes such as
specification, proliferation, migration, differentiation and survival will be important
mediators in directing stem cell therapy for CNS repair. As such, Pax genes are prime
candidates for enhancement of future replacement strategies (Figure 3).

Figure 3. Schematic of Pax function and downstream targets during CNS development,
including cellular specification and regionalisation (a), progenitor expansion (b), neural cell
migration (c), maintenance of the undifferentiated phenotype (d), differentiation, and
maintenance of differentiated cells by cell survival and anti-apoptotic mechanisms (e). Listed
target genes apply to one or more listed Pax proteins. Throughout these processes, Pax
functions are concentration-dependent.

Due to very early neural expression and their capacity for neuronal specification, Pax genes
may be powerful tools in directing differentiation pathways along desired routes, particularly
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when manipulation of alternate isoforms or co-factors can be used to specify desired
subtypes. In addition, Pax genes can specify progenitors that differentiate into radial glia,
projection neurons, interneurons, astrocytes, oligodendrocytes and schwann cells (Chan-Ling
et al., 2009; Kioussi et al., 1995; Mo and Zecevic, 2008; Pillai et al., 2007; Sugimori et al.,
2007), and this may prove beneficial when use of heterogeneous populations may maximise
repair and regeneration strategies. Furthermore, the ability to maintain a stem/progenitor cell
phenotype and promote cellular survival provides a sound rationale for harnessing Pax genes
for future stem cell therapies. These results also highlight the critical need for further work to
reveal the identity and nature of other co-factors (eg epigenetic factors, upstream or
downstream targets) that participate with Pax genes during these crucial developmental
processes, and the functional peculiarity of isoforms to identify how, essentially, one
transcription factor can multi-task and direct such diverse functional outcomes.

More

research detailing the capacity of Pax genes to supplement current repair strategies is likely to
be beneficial.

Further considerations for future success of transplantation therapies will include the site of
transplantation, the type of cell chosen and the transplant environment. The striatum has
previously been chosen as the site of foetal graft transplantation in Parkinson’s disease,
however functional recovery is incomplete in human (Lindvall and Hagell, 2000) and animal
models (Annett et al., 1994; Winkler et al., 2000) and is thought due to ectopic placement of
the grafts in an unfavourable microenvironment or lack of afferent input to grafted cells
(Gaillard et al., 2009; Thompson et al., 2009). However, new research has indicated that
foetal ventral mesencephalic cells transplanted into the 6-OHDA-lesioned adult mouse
substantia nigra can integrate and restore the nigrostriatal pathway (Gaillard et al., 2009;
Thompson et al., 2009) and this is enhanced with addition of appropriate neurotrophic
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support (Thompson et al., 2009).

Moreover, whilst foetal ventral mesencephalic cells

transplanted into the substantia nigra produce dopaminergic cells capable of projecting to the
striatum and restoring the nigrostriatal pathway, dopaminergic cells from the embryonic
olfactory bulb do not (Gaillard et al., 2009), indicating that intrinsic qualities of the cell
impact its transplant capability and therefore matching transplanted cells with their
environment may significantly influence transplant success.

Similarly, embryonic stem cells matured within tissue explants, allowing extrinsic signals
within the tissue to direct maturation, appears favourable for the production of neural stem
cells with the potential to recapitulate the dopaminergic development programme within the
ventral mesencephalon. However, neuralization of these cells within explants produces more
mature cells with a high neurogenic potential but low capacity to respond to environmental
cues for site-specific differentiation, indicating that with progressive cellular maturation
comes restricted plasticity (Baizabal and Covarrubias, 2009). This agrees with previous
findings determining that in early stages of mesencephalic development, cells have a greater
capacity to respond to extrinsic signals, and early progressive maturation is driven more by
extrinsic (non-cell autonomous), rather than intrinsic (cell autonomous) cues.

As cell

maturation progresses, however, cells become more reliant on intrinsic qualities for
specialisation of function (Li et al., 2005). Nevertheless, such use of an “instructive niche”
may circumvent the need for modulating culture conditions to suit different spatiotemporal
requirements (Baizabal and Covarrubias, 2009), as the plethora of contributing factors that
must precisely intersect for correct cellular specification, as demonstrated in this review, is a
daunting prospect. Taking these considerations into account, this protocol may provide an
avenue to correctly ascribe Pax gene expression to improve transplant outcome when the
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transplant environment (eg adult or post-traumatic) demonstrates poor efficacy to instruct the
immature cell along a differentiation pathway.
Sadly, there has been scarcity in the recent literature detailing Pax gene use in manipulation
of stem/progenitor cells for transplant therapies. Perhaps the complexity of the task has
proved too intimidating. It is obvious from the research cited in this paper that Pax gene
levels, alternate isoforms, co-factors and co-operation with paralogues (or other Pax genes)
are required for correct structural and cellular determination. To mimic this level of precision
within stem or progenitor cells before or after transplantation is a challenging task but
appears plausible if the Pax master switch is provided in the right context. The ultimate
question here is whether it is possible, using individual Pax genes, to recapitulate these
processes and produce specific neurons from stem/progenitor cells within an in vitro
situation. Given that Pax gene dosage is a critically sensitive variable in defining cell
outcome, and the requirement for definitive upstream regulators of Pax genes (dynamic from
a temporospatial perspective), it is tempting to speculate that use of a suitable “instructive
niche” to generate and foster appropriate Pax expression levels prior to transplantation may
provide a powerful mechanism to produce cells for neuro-restorative purposes. Further
research in this area should provide exciting results.

Some success has been achieved where the capacity of Pax genes to specify neurons in
embryonic or adult multipotent stem cells and enhance their proliferation and survival has
been trialled for both endogenous and exogenous sources. In particular, Pax6 has received
noteworthy interest due to the capacity for cortical neurogenesis (Berger et al., 2007; EstivillTorrus et al., 2002; Sansom et al., 2009) and specification of dopaminergic neurons (Kohwi
et al., 2005) for neurodegenerative diseases such as Parkinson’s disease. Recent experiments
demonstrate that Pax6 expression in embryonic stem cells directs neuroectoderm progression
34

toward a radial glial fate (neuronal precursors) (Suter et al., 2009). Moreover, use of Pax6positive or Pax6-negative embryonic stem cells cultured in appropriate conditions prior to
transplantation can give rise to glutamatergic or GABAergic cortical cells, respectively
(Nikoletopoulou et al., 2007).

Whilst progression of neural stem cells in vitro toward a neuronal fate historically has been
poor, Pax6 overexpression in neurosphere cultures has been shown to direct neuronogenesis
in almost all neurosphere-derived cells in vitro (Hack et al., 2004). Similarly, when Pax6
protein was delivered into E12 rat ventral mesencephalic neurosphere cultures, the neuronal
progenitors increasingly adopted a dopaminergic fate (Spitere et al., 2008). In a transplant
scenario, Kallur et al (2008) achieved increased generation of neuronal cells after
transplanting Pax6-overexpressing human striatal neural stem cells into neonatal rat striatum.

It appears, however, that definitive cell lineage determination may be more specifically
achieved by alternate isoforms. Pax7 isoforms can direct distinct lineages as suggested by
varied expression patterns during development; myogenic-derived Pax7b induces neuronal
differentiation in P19 embryonal carcinoma cells (Ziman et al., 1997; Ziman et al., 2001b).
Likewise, Pax6-5a isoform induces neuronal differentiation in murine embryonic stem cells
in vitro, in contrast to the canonical Pax6 isoform, and it does so by regulating expression of
bHLHb2 and Oct3/4 (Shimizu et al., 2009). Autoregulatory functions of Pax6 isoforms also
stabilise relative levels of isoforms to achieve the desired outcome (Pinson et al., 2005;
Pinson et al., 2006). These results collectively highlight the capacity for Pax genes to specify
desired lineages for stem cell therapies, however knowledge of correct co-factors will be
required.
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As the use of human embryonic stem cells or foetal tissue for neuroregeneration is
contentious due to ethical considerations and availability of tissue, identifying suitable cell
types to circumvent this issue is crucial. Adult stem cells are potential candidates that have
the added feature of autology, eliminating immunological rejection of the transplant. Adult
stem cells may be harvested from an affected individual, re-specified (using Pax genes, for
example) to produce the cell type of interest and transplanted back at the affected site.
However, preparing cells in this manner for neurorepair will require fundamental knowledge
of the key factors required to produce a “designer” cell of interest. For instance, bone
marrow-derived adult human mesenchymal stem cells exhibit a predisposition for neural
differentiation and express Pax6 in vitro under the appropriate conditions (Blondheim et al.,
2006) and hence achieve some functional repair when transplanted into various rat models of
brain and spinal cord injury (Chen et al., 2001; Chopp et al., 2000; Li et al., 2001; Lu et al.,
2001; Mahmood et al., 2001).

In order to achieve functional improvements after transplantation, the chosen cell type should
be compatible with the host brain region and must be capable of integrating into circuitry
regulated by the host brain environment (Isacson, 2003). Achieving an optimum match
between cell and target site may require manipulation of the cell and/or the environment, and
may be augmented by the use of factors such as neurotrophins (Choi et al., 2010; Thompson
et al., 2009; Yang et al., 2010). In support of this, mesencephalic neuroepithelial stem cells
grafted into damaged rat striata show increased survival and differentiation tendencies
compared to grafts into intact striata, indicating the powerful influence of the environment on
the cell (Mine et al., 2009).
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Interestingly, a variety of stem cell types have been used to repair the retina, albeit with
differing levels of success. Ciliary retinal stem cells from the adult human eye (Pax6positive) have shown some success in integrating and differentiating into photoreceptors and
retinal pigmented epithelia post-transplant in postnatal NOD/SCID mice and embryonic chick
retinae (Coles et al., 2004), whereas some studies have shown that neural stem cells fail to
fully differentiate into retinal phenotypes (reviewed in Baker and Brown, 2009), highlighting
differences in transplant response which may be due to the potency of the cells chosen and
their more closely-matched compatibility with the environment. A recent study assessed the
capacity for Pax7 to enhance CNS repair by matching the transcription profile of donor cells
to that of the host tissue. Pax7-expressing neural progenitor cells taken from embryonic rat
dorsal mesencephalon were grafted within the adult rat dorsal mesencephalon (Pax7-positive)
or ventral mesencephalon (Pax7-negative), and whilst overall graft survival did not vary, the
number of resultant astrocytes was reduced when Pax7-expressing cells were grafted into a
non-Pax7-expressing region (Thomas et al., 2009).

These experiments also highlight the

capacity of Pax-expressant cells to withstand inflammation and trauma (Edwards et al.,
1986a; Finlay et al., 1982), possibly due to transcriptional regulation of survival factors
(reviewed in Medic and Ziman, 2009; Ninkovic et al., 2010; White and Ziman, 2008) - an
important feature that will significantly assist in neuroregenerative strategies.

It is apparent then that successful cell replacement requires knowledge of the appropriate cell
type and maturation stage (Denham et al., 2010). Pre-differentiation of cells in vitro into the
appropriate cell type/s and maturation stage prior to transplantation has been attempted with
variable success (Baizabal and Covarrubias, 2009; Le Belle et al., 2004; Park et al., 2009),
possibly due to other factors inhibiting the in vivo uptake, integration and survival of mature
transplanted cells within the injured environment.

Another possible source of cells for
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transplantation is via the targeted de-differentiation of mature cells, such as the use of
pigment cells de-differentiated in culture conditions to produce neural crest-derived ancestor
cells (Real et al., 2006). Correspondingly, forced expression of Pax6 in postnatal cortical
astroglia can instruct neurogenesis (Berninger et al., 2007; Heins et al., 2002), and under
appropriate culture conditions, Pax6 transfection into mouse embryonic stem cells results in
cell-fate adaptation to corneal epithelial-like cells (Ueno et al., 2007). Similarly, Pax6 can
affect adult multipotent stem cell lineage specification; Pax6 upregulation results in transdifferentiation of hair follicle stem cells into corneal epithelial-like cells in conditioned media
(Yang et al., 2009) or retinal pigmented epithelia into neuroretina in chick and Xenopus
embryos (Arresta et al., 2005; Azuma et al., 2005).

Environmental factors subsequent to inflammation and injury also significantly influence
neuroregenerative therapies. In Huntington’s disease, inherent immunological functions may
cause degeneration of striatal grafted cells, which show differential survival rates in the
caudate compared to the putamen (Cicchetti et al., 2009). Similarly, in Parkinson’s disease
Lewy bodies may eventually form in grafted cells (Kordower et al., 2008a; Kordower et al.,
2008b; Li et al., 2008). However, whilst neuroinflammatory processes have generally been
considered a negative component of CNS repair, evidence is emerging that chemokines and
cytokines of the early immune response, involved in attracting inflammatory cells, also attract
stem cells to the area of injury (Imitola et al., 2004; Newman et al., 2005). Therefore, injuryinduced factors may positively affect transplant success, as demonstrated by the capacity of
retinal stem cells to incorporate into the lesioned rat retina (Chacko et al., 2003), and likewise
the migration of neural stem cells to infarcted areas due to mediators of the inflammatory
response (Imitola et al., 2004). Furthermore, the inability of pre-differentiated neurons and
the capacity of stem cells to migrate to injury sites indicates a certain level of plasticity is
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required for correct migration to pathological sites, or that differentiated cells respond
differently to migration/survival cues (Park et al., 2009), and this will impact the maturity
level of cells chosen or definitive Pax isoform selected for different applications, as cell
migration after transplant is not always a desirable characteristic.

Therefore, the use of transcription factors to “prime” cells by matching the genetic profile of
transplanted cells to the damaged environment may optimise transplant success (Kallur et al.,
2008; Thomas et al., 2009).

Moreover, conditions that manipulate this dictated gene

expression and the cell type chosen to exploit it, as well as the ability to manipulate the
environment for graft uptake, will depend upon the nature of the condition being assessed.
Thus to successfully manipulate cells to survive, integrate and mature to produce significant
functional restoration to circuitry and information processing after in vitro conditioning
requires investigation specific for each condition (Baizabal and Covarrubias, 2009;
Srivastava et al., 2008). Additionally, the appropriate use of stem cell survival factors
(including Pax) to assist with transplant survival (Pluchino et al., 2010; Sieber-Blum, 2010)
may be utilised to improve graft outcomes.

12.

FURTHER CONSIDERATIONS

Whilst it is clear that Pax transcription factors possess many promising features that offer
substantial promise for CNS regenerative strategies, their anti-apoptotic and oncogenic
potential, as detailed below, will require further consideration when utilising Pax genes for
neuroregenerative purposes.

Correct embryo formation is also critically achieved by regulating apoptosis to create the
optimal number of cells and/or architecture of the developing tissue, particularly in the CNS.
39

Pax genes mediate cell survival by inhibiting apoptosis in many regions of the body to direct
organogenesis or for maintenance of normal homeostatic mechanisms. In Pax2-/- mice, optic
stalk cells degenerate (Schwarz et al., 2000), and Pax2+/- mice exhibit renal-coloboma
syndrome. When a Pax5 minigene is inserted into the Pax2 locus, most functionality is
restored due to redundancy, however symptoms similar to Pax2+/- remain in the kidney and
eye. Whilst cell proliferation is normal, there is increased apoptosis (Bouchard et al., 2000),
revealing a dosage-dependent, anti-apoptotic role for Pax2. Within the mouse kidney, Pax2
protects against osmotic-induced apoptosis (Cai et al., 2005) by indirectly regulating the antiapoptotic gene bcl-2 via the transcription factor WT1 (Bouchard et al., 2000), similar to the
indirect regulation of bcl-XL by Pax5 during B-lymphopoiesis (Nutt et al., 1998). Direct
modulation of bcl-2 (homologue ced-9) by Pax2/5/8 genes has been demonstrated in
C.elegans (Park et al., 2006). Moreover, Pax2/5/8 expression is inversely correlated with
expression of the tumour suppressor gene p53 in astrocytoma and directly inhibits activity of
the p53 promoter in vitro (Stuart et al., 1995a; Stuart et al., 1995b). Pax8 also activates the
anti-apoptotic TERT (Telomerase Reverse Transcriptase) gene in glioma cell lines,
implicating it in glioma cell survival (Chen et al., 2008).

An anti-apoptotic role for Pax3 is demonstrated by Pax3 inhibition secondary to maternal
diabetes (Phelan et al., 1997), whereby neuroepithelial cells undergo apoptosis via p53dependent mechanisms (Pani et al., 2002), explaining neural tube defects induced in diabetic
pregnancy. This was demonstrated by the rescue of anti-apoptotic function in Pax3-/- mice
with p53 loss-of-function (Pani et al., 2002), and by the observation that Pax3 inhibits p53
activity in vitro by modulating its transcriptional activity and by promoting degradation of
the p53 protein (Underwood et al., 2007).
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Evidence for an anti-apoptotic function of Pax6 was recently demonstrated whereby Pax6
regulated survival of dopaminergic OB neurons during adult neurogenesis via direct
regulation of crystallin-αA, which prevents activation of the caspase cascade and thus
inhibits programmed cell death (Ninkovic et al., 2010). Pax6 also negatively regulates
expression of the neurotrophic receptor p75NTR (Nikoletopoulou et al., 2007), demonstrated
to cause neuronal death when overexpressed (Majdan et al., 1997; Plachta et al., 2007).
Therefore, Pax6 mutant mice exhibit premature neuronal differentiation accompanied by
rapid cell death of mis-specified neurons (Nikoletopoulou et al., 2007).

Thus

it

appears

that

Pax

genes

couple

early stages

of

neural

development

(specification/maintenance) to later stages (differentiation/maintenance) by providing antiapoptotic mechanisms throughout these processes, and this may also be differentially
achieved using alternate isoforms and their subsequent ability to discriminate distinct
downstream targets (Wang et al., 2007; Wang et al., 2006; Zhang et al., 2010). Indeed,
investigation of Pax3 isoforms stably transfected into mouse melanocytes in vitro has
demonstrated differing isoform-specific effects on cell function, which is achieved by
differential regulation of distinct downstream targets, including genes involved in
proliferation and survival (Rac1), differentiation (Dhh), transcriptional repression of Pax3
(Msx1) and migration/transformation (Met, Muc18) (Wang et al., 2007; Wang et al., 2006).
Whilst this feature is advantageous in the context of normal developmental processes, it may
have deleterious consequences from an oncogenic perspective in putative regeneration
strategies.

Whilst not a focus of this review, a discussion of Pax gene function in cell replacement
therapy would not be complete without due regard to their oncogenic potential (refer Wang et
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al., 2008 for comprehensive review), due to the risk of instigating tumourigenesis when using
non-terminally differentiated cells (Heine et al., 2004; Johnson et al., 2008). Pax genes are
implicated in a wide variety of cancers, presumably due to regulation of proliferation, cell
cycle arrest, migration and cell survival, and it has been proposed that different Pax groups or
different Pax isoforms may pose a greater cancer risk due to structural and functional
variation (Robson et al., 2006; Wang et al., 2008; Wang et al., 2007; Wang et al., 2006).

Pax8 is overexpressed in glioma (Tong et al., 2008), and Pax3 and Pax7 are expressed in a
variety of neuroectodermal tumours (Gershon et al., 2005).

However, whilst Pax5

deregulation and overexpression have been reported in medulloblastoma (Kozmik et al.,
1995) and expression noted in astrocytoma (Stuart et al., 1995b), manipulation forcing
overexpression in an effort to induce brain tumour formation from mouse neuroectoderm was
unsuccessful (Steinbach et al., 2001), suggesting caution when inferring causality from
expression patterns. Conversely, the association of Pax5 with haematopoietic cancers such as
B-Cell lymphoma (Busslinger et al., 1996) and acute lymphoblastic leukaemia (Nebral et al.,
2007), together with small cell-lung cancer (Kanteti et al., 2009) suggests tissue-specific
oncogenic capabilities (Steinbach et al., 2001). Knockdown of Pax2 (ovarian/bladder) or
Pax3 (melanoma) in cancer cell lines (Muratovska et al., 2003), and Pax3 and Pax7 in
alveolar rhabdomyosarcoma cells (Bernasconi et al., 1996), results in rapidly induced
apoptosis, with a demonstrated anti-apoptotic pathway being the negative association
between Pax genes and p53 (Stuart et al., 1995a; Underwood et al., 2007). Collectively,
these data suggest that Pax genes may bestow a cell survival mechanism on cancer cells,
protecting them from normal elimination processes. This risk may, however, be reduced with
careful choice of the appropriate Pax isoform.
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13.

CONCLUSION

As demonstrated in this review, Pax genes participate in almost all facets of CNS
development, from the earliest to mature stages.

Whilst their function in mature,

differentiated adult cells still proves enigmatic, there is a wealth of evidence identifying
complex and important roles for Pax genes in orchestrating and co-ordinating multiple
aspects of neural maturation.

Initially, Pax genes dictate correct organogenesis by ensuring sufficient progenitor cells for
organ development. This will impact stem cell therapies by ensuring initial expansion of
cells if culture conditions can recapitulate this in vitro. Secondly, the capacity for Pax genes
to maintain the undifferentiated status of the cell until directed to switch towards
differentiation allows for a variable, spatiotemporal-driven specification capable of producing
different mature cell types within a changing developmental niche. This demonstrates their
aptitude as multipotent switches, instructing cells along differential pathways depending on
the cell history and its spatial placement (Torres et al., 1996), providing credence for the
previously suggested paradigm of Pax function; the capacity to couple extrinsic
(environmental) and intrinsic (cellular) signals by rendering the Pax-expressant cell
responsive to spatiotemporal environmental cues (Blake et al., 2008). This feature affords a
powerful tool for stem cell therapy, provided the appropriate Pax expression can be partnered
with a correctly instructed and permissive environment.

The challenge in harnessing Pax genes for stem cell therapy will not only lie in matching Pax
and environment, but also in producing a cell with a correct complement of Pax dosage,
including relative isoform levels, that is compatible with the environment at that point in time
and place to achieve the desired outcome. The Pax family of genes display crucial, dosage43

dependent mechanisms for many functions (Hill et al., 1991; Kanakubo et al., 2006;
Maekawa et al., 2005; Thompson et al., 2008; Zhou et al., 2008), and overexpression has
been implicated in tumourigenesis. For this reason, it is questionable whether transfection
techniques can correctly assign Pax expression to a cell from a dosage perspective, and it
may be more efficacious to use the “instructive niche” concept (Baizabal and Covarrubias,
2009) utilising the appropriate environment for onset of Pax expression.

Importantly, the ability of Pax genes to specify multiple cell lineages may have significant
applications for therapeutic interventions requiring multiple cellular phenotypes. It will be
crucial to understand which Pax isoforms and downstream targets facilitate cell fate choice as
this can be exploited to direct differentiation to desired populations as required. Furthermore,
the perceived capacity for Pax genes to respond to injury or stress suggests that either Pax
genes may recapitulate the embryonic state for regenerative purposes, or highlights their roles
as pro-survival/anti-apoptotic mediators. It is clear that neuroinflammatory processes
themselves greatly influence remedial therapy, and stem cell therapies must be able to
withstand these processes. It will therefore be necessary to identify what (if any)
regeneration signals Pax genes respond to in the CNS and how these Pax-expressant cells
interact with a damaged or regenerating environment. This will provide further insight into
the applicability of Pax genes for CNS repair.
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